The effect of ketorolac on postoperative febrile episodes in patients after abdominal myomectomy

American Journal of Obstetrics and Gynecology

Volumn 187, Issue 6, 2002, Pages 1450-1455

  Held, Barbara I ^a   Michels, Anne ^a   Blanco, Jody ^a   Ascher Walsh, Charles ^a   Strohbehn, Kris ^b  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b NYP Columbia University Campus ^*

Author keywords

Ketorolac; Myomectomy; Operative complications

Indexed keywords

ANTIINFLAMMATORY AGENT; KETOROLAC; SODIUM CHLORIDE;

ABDOMINAL SURGERY; ADULT; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CONVALESCENCE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; FEMALE; FEVER; HUMAN; MAJOR CLINICAL STUDY; MYOMECTOMY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 0036910363     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1067/mob.2002.130006     Document Type: Conference Paper

References (14)

1. Iverson RE, Chelmow D, Strohbehn K, Waldman L, Evantash E, Aronson MP. Myomectomy fever: Testing the dogma. Fertil Steril 1999;72:104-8.
2. Tilley SL, Coffman TM, Koller BH. Mixed messages: Modulation of inflammation and immune responses by prostaglandins and thromboxane. J Clin Invest 2001;108:15-23.
3. Ushikubi F, Segi E, Sugimoto Y, Murata T, Matsuoko T, Kobayashi T, et al. Impaired febrile response in mice lacking the prostaglandin E receptor subtype EP3. Nature 1998;205:281-4.
4. Sevarino FB, Sinatra RS, Paige D, Silverman DG. Intravenous ketorolac as an adjunct to patient-controlled analgesia (PCA) for management of post gynecologic surgical pain. J Clin Anesth 1994;6:23-7.
5. Balestrieri P, Simmons G, Hill D, Brown J, Jackson A, Brull SJ, et al. The effects of intravenous ketorolac given intraoperatively versus postoperatively on outcome from gynecologic surgery. J Clin Anesth 1997;9:358-64.
6. Vangen O, Doesslan S, Lindbaek E. Comparative study of ketorolac and paracetamol/codeine in alleviating pain following gynaecologic surgery. J Int Med Res 1988;16:443-51.
7. LaMorte AI, Lalwani S, Diamond M. Morbidity associated with abdominal myomectomy. Obstet Gynecol 1995;82:897-900.
8. Parker RK, Holtman B, Smith I, White PF. Use of ketorolac after lower abdominal surgery. Anesthesiology 1994;80:6-12.
9. Gabbott DA, Cohen AM, Mayor AH, Niemiro LA, Thomas TA. The influence of timing of ketorolac administration on postoperative analgesic requirements following total abdominal hysterectomy. Eur J Anaesthesiol 1997;14:610-5.
10. Gillis JC, Brogden RN. Ketorolac: A reappraisal of its pharmaco-dynamic and pharmacokinetic properties and therapeutic use in pain management. Drugs 1997;53:139-88.
11. Pasloske K, Burger J, Conlon P, Plasma prostaglandin E2 concentration after single administration of ketorolac tromethamine (Torodol) in dogs. Can J Vet Res 1998;62:237-40.
12. Zhang Y, Shaffer A, Portanova J, Siebert K, Isakson PC. Inhibition of cyclooxygenase-2 rapidly reverses inflammatory hyperalgesia and prostaglandin E2 production. J Pharm Exp Ther 1997;283:1069-75.
13. Ostrov CS, Sirkin SR, Deutsch WE, Masi RJ, Chandler JW, Lindquist TD. Ketorolac, prednisolone, and dexamethasone for postoperative inflammation. Clin Ther 1997;19:259-72.
14. Fragen RJ, Stulberg SD, Wixson R, Glisson S, Librojo E. Effects of ketorolac tromethamine on bleeding and on requirements for analgesia after total knee arthroplasty. J Bone Joint Surg 1995;77:998-1102.